University of Southampton
Perfluorocarbon nanodroplets for oxygen delivery for bone repair
Abstract
dc:description.abstractAround 2-10% of bone fractures result in delayed or non-union fractures.<br/>These typically require surgery, which can be painful and carry a risk of infection.<br/>There is, therefore, a critical need for minimally invasive treatment methods.<br/>Many bone diseases linked to unsuccessful fracture healing, like osteoporosis and<br/>osteonecrosis, are associated with hypoxia. Perfluorocarbons are inert and have<br/>very high oxygen solubilities. They can be stabilised in aqueous solutions to form<br/>nanodroplets. These perfluorocarbon nanodroplets have previously been shown<br/>to successfully increase the oxygen tension in tumours. This study tested the hypothesis<br/>that perfluorocarbon nanodroplets relieve the effects of hypoxia on cells<br/>of osteoblastic and osteoclastic lineage in a manner that aids bone repair.<br/>Perfluoropentane (PFP) nanodroplets with a 1,2-distearoyl-sn-glycero-3-<br/>phosphocholine (DSPC) and polyoxyethylene (40) strearate (PEG(40)s) shell were<br/>fabricated using sonication. Temperature, PFP concentration, sonicator tip height,<br/>total sonication time, sonication amplitude and post-processing techniques were<br/>varied to evaluate their effect on nanodroplet characteristics through nanoparticle<br/>tracking analysis. The optimised formulation was investigated for cytotoxicity on<br/>cells of both osteoblastic (MC3T3E1, Saos-2 and BMSC) and osteoclastic (PBMC)<br/>lineages using Alamar blue, Picogreen and cell counting. Alkaline phosphatase<br/>enzyme and calcification served as osteogenic markers in BMSCs exposed to<br/>the nanodroplets in normoxia and hypoxia, while osteoclastic activity was<br/>measured by manually assessing osteoclast number and size in peripheral blood<br/>mononuclear cells (PBMCs). Hypoxic stress was measured by quantifying HIF-1<br/>protein expression in Saos-2s by western blotting and VEGF secretion by ELISA.<br/>Nanodroplets exhibit low cytotoxicity on osteoblastic cells but significantly reduce<br/>osteoclast numbers. Treatment with 0.1% v/v nanodroplets led to a marked<br/>increase in calcification. Osteoclast number and size were evaluated manually after<br/>long-term nanodroplet treatment. A decrease in osteoclast number and size<br/>when treated long-term occurred in both normoxia and hypoxia, while short-term<br/>treatment reduced osteoclast numbers in normoxia but increased them in hypoxia.<br/>Microscope examination showed a preferential association of nanodroplets with<br/>phagocytic cells over other cell types.<br/>This work demonstrated that precise control over sonication parameters enables<br/>better control over nanodroplet size and repeatability. The resulting nanodroplets<br/>were capable of significantly increasing mineralisation and decreasing<br/>hypoxic stress in osteoblastic cells, as well as relieving hypoxia-induced apoptosis<br/>in osteoclastic cells. Overall, nanodroplets present a promising new oxygen delivery<br/>method for relieving hypoxic stress in bone cells.
Degree
thesis:*- Name dc:type.qualificationname
- Ph.D.
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- University of Southampton
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- O'Brien, Kirsten Emma
- Advisor dc:contributor.advisor
-
- Evans, Nick
- ORCID person:identifier.orcid
Rights
- Language dc:language
- English, eng